VanEck Biotech ETF
BBH
BBH
83 hedge funds and large institutions have $67.8M invested in VanEck Biotech ETF in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 30 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
10% less capital invested
Capital invested by funds: $75.4M → $67.8M (-$7.53M)
57% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 30
Holders
83
Holding in Top 10
–
Calls
$1.27M
Puts
$1.4M
Top Buyers
| 1 | +$1.2M | |
| 2 | +$640K | |
| 3 | +$595K | |
| 4 |
PA
PFG Advisors
Phoenix,
Arizona
|
+$270K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$250K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$1.92M | |
| 3 | -$1.37M | |
| 4 |
Jane Street
New York
|
-$1.21M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$833K |